Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AMD 3465 hexahydrobromide (GENZ-644494 (hexahydrobromide)) is a CXCR4 receptor antagonist with potential anticancer and anti-HIV activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 51.00 | |
10 mg | In stock | $ 72.00 | |
25 mg | In stock | $ 141.00 | |
50 mg | In stock | $ 243.00 | |
100 mg | In stock | $ 383.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | AMD 3465 hexahydrobromide (GENZ-644494 (hexahydrobromide)) is a CXCR4 receptor antagonist with potential anticancer and anti-HIV activity. |
Targets&IC50 | X4 HIV-1 (IIIB):12.3 nM (IC50, in MT-4 cells), HIV-2 (ROD):12.3 nM (IC50, in MT-4 cells), HIV-2 (EHO):12.3 nM (IC50, in MT-4 cells), X4 HIV-1 (NL4.3):6.1 nM (IC50, in MT-4 cells), X4 HIV-1 (HE):9.8 nM (IC50, in MT-4 cells), CXCL12 (AF647)-CXCR4:18 nM (IC50, in SupT1 cells), 12G5 mAb-CXCR4:0.75 nM (IC50, in SupT1 cells), X4 HIV-1 (NL4.3AMD3100):2822 nM (IC50, in MT-4 cells), X4 HIV-1 (RF):7.4 nM (IC50, in MT-4 cells) |
In vitro | AMD 3465 hexahydrobromide inhibits binding of 12G5 mAb and CXCL12AF647 to CXCR4, with IC50s of 0.75 nM and 18 nM in SupT1 cells.?AMD 3465 (50 nM) totally blocks CXCL12-induced calcium mobilization, with an IC50 of 17 nM, but shows no effect on the intracellular calcium fluxes elicited by the CCR5 ligands RANTES, LD78β and MIP-1β in U87.CD4.CCR5 cells.?AMD 3465 also potently inhibits the replication of X4 HIV strains (IC50: 1-10 nM), but has no effect on CCR5-using (R5) viruses.?AMD3465 is cytotoxic to the X4 HIV-1 strains IIIB, NL4.3, RF and HE with an IC50 ranging from 6 to 12 nM.?The IC50 for suppression of the HIV-2 strains ROD and EHO is 12.3 nM[1].?AMD 3465 inhibits CXCL-12-induced growth in U87 and Daoy cells.?AMD 3465 treatment stimulates the phosphorylation of Erk1/2 in U87 and Daoy cells[2]. |
In vivo | Administering 2.5 mg/kg/d of AMD 3465 subcutaneously for five weeks significantly inhibits the growth of U87 glioblastoma multiforme (GBM) and Daoy medulloblastoma xenografts. |
Synonyms | GENZ-644494 (hexahydrobromide) |
Molecular Weight | 896.07 |
Formula | C24H44Br6N6 |
CAS No. | 185991-07-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 38 mg/mL (42.41 mM)
DMSO: 50 mg/mL (55.80 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AMD 3465 hexahydrobromide 185991-07-5 Autophagy GPCR/G Protein Immunology/Inflammation Microbiology/Virology Proteases/Proteasome CXCR HIV Protease Inhibitor AMD-3465 Hexahydrobromide GENZ 644494 AMD3465 GENZ-644494 (hexahydrobromide) HIV AMD 3465 Hexahydrobromide GENZ644494 CXC chemokine receptors GENZ-644494 hexahydrobromide inhibit AMD3465 Hexahydrobromide AMD-3465 AMD 3465 Human immunodeficiency virus GENZ-644494 inhibitor